Soren Bini Chhetri, Dasari Jagadish Babu, Ottaviani Alessio, Iacovelli Federico, Fiorani Paola
Department of Biology, University of Rome Tor Vergata, Rome 00133, Italy.
Present address: Department of Research and Application Development, Biogenex Life Sciences, Telangana 501510, India.
Cancer Drug Resist. 2020 Mar 19;3(1):18-25. doi: 10.20517/cdr.2019.106. eCollection 2020.
DNA topoisomerase I enzymes relieve the torsional strain in DNA; they are essential for fundamental molecular processes such as DNA replication, transcription, recombination, and chromosome condensation; and act by cleaving and then religating DNA strands. Over the past few decades, scientists have focused on the DNA topoisomerases biological functions and established a unique role of Type I DNA topoisomerases in regulating gene expression and DNA chromosome condensation. Moreover, the human enzyme is being investigated as a target for cancer chemotherapy. The active site tyrosine is responsible for initiating two transesterification reactions to cleave and then religate the DNA backbone, allowing the release of superhelical tension. The different steps of the catalytic mechanism are affected by various inhibitors; some of them prevent the interaction between the enzyme and the DNA while others act as poisons, leading to TopI-DNA lesions, breakage of DNA, and eventually cellular death. In this review, our goal is to provide an overview of mechanism of human topoisomerase IB action together with the different types of inhibitors and their effect on the enzyme functionality.
DNA拓扑异构酶I可缓解DNA中的扭转张力;它们对于DNA复制、转录、重组和染色体浓缩等基本分子过程至关重要;其作用方式是切割然后重新连接DNA链。在过去几十年中,科学家们一直专注于DNA拓扑异构酶的生物学功能,并确立了I型DNA拓扑异构酶在调节基因表达和DNA染色体浓缩方面的独特作用。此外,人类的这种酶正作为癌症化疗的靶点进行研究。活性位点酪氨酸负责启动两个转酯反应,以切割然后重新连接DNA主链,从而释放超螺旋张力。催化机制的不同步骤会受到各种抑制剂的影响;其中一些抑制剂会阻止酶与DNA之间的相互作用,而另一些则起到毒性作用,导致拓扑异构酶I-DNA损伤、DNA断裂,并最终导致细胞死亡。在这篇综述中,我们的目标是概述人类拓扑异构酶IB的作用机制以及不同类型的抑制剂及其对酶功能的影响。